Hap Trading, LLC Ligand Pharmaceuticals Inc Call Options Transaction History

Hap Trading, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2021 Aug 11, 2021	SELL	$113.03 - $155.64 $1.14 Million - $1.57 Million	-10,100 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$99.52 - $215.83 $1.01 Million - $2.18 Million	10,100 New	10,100 $166,000
Q1 2019 May 10, 2019	SELL	$105.93 - $142.47 $16.1 Million - $21.7 Million	-152,200 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$128.36 - $272.13 $19.5 Million - $41.4 Million	152,200 New	152,200 $69,000

276

18.5M

30.8K

5.2K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.85B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.